Navigation Links
Prime Therapeutics Receives VIPPS Accreditation
Date:5/21/2008

also include useful tools such as drug research options that allow members to review specific drug information, a complete prescription history list and a cost calculator that offers side by side cost comparisons of brand-name and generic drugs at both PrimeMail and retail pharmacies.

Prime Therapeutics is a pharmacy benefit management company dedicated to providing, innovative, clinically-based, cost-effective pharmacy solutions for clients and members. Providing pharmacy benefit services nationwide to approximately 14.6 (legal) million covered lives, its client base includes Blue Cross and Blue Shield Plans, employer and union groups, and third-party administrators. Headquartered in St. Paul, Minnesota, Prime Therapeutics is collectively owned by ten Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those Plans. Learn more at http://www.primetherapeutics.com.

NABP is the independent, international, and impartial Association that assists its member boards and jurisdictions in developing, implementing, and enforcing uniform standards for the purpose of protecting the public health.


'/>"/>
SOURCE Prime Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Primera Biosystems Raises $21 Million in Series B Private Round
2. Alba Therapeutics Announces the Enrollment and Randomization of the First Patient in the Phase IIb Clinical Trial for Larazotide Acetate (AT-1001) for the Treatment of Active Celiac Disease
3. ImaRx Therapeutics Reports First Quarter Ended 2008 Financial Results
4. Cell Therapeutics, Inc. (CTI) to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference
5. Nile Therapeutics Reports 2008 First Quarter Financial Results
6. Fate Therapeutics Taps Successful Biotech CEOs Paul Grayson and John Mendlein for Leadership Team
7. Vista Partners Initiates Coverage on Synvista Therapeutics, Inc. (AMEX: SYI)
8. Amicus Therapeutics Announces First Quarter 2008 Financial Results
9. Nile Therapeutics to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
10. Synvista Therapeutics Announces Initiation of the BREAK Study of Alagebrium for Diastolic Heart Failure
11. Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 5th Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/5/2015)... Brooklyn, NY (PRWEB) , ... July 06, 2015 , ... ... spectrophotometers. If a user had a high-end machine such as a Varian Cary 4000-7000, ... charm. So widespread was this design that even NIST used them for their SRM-2031 ...
(Date:7/3/2015)... ... July 03, 2015 , ... The Alexander Group, a 30-year ... industries alike-- typically known for its consummate professionalism-- embarks each year in a ... break from their day jobs. , "Our motto has always been work hard ...
(Date:7/3/2015)... Forskere kan søke ... Science", som finner sted i ... på  http://www.openinnovationinscience.at , og søknadsperioden varer frem ... to største utfordringene innen helsevitenskapen er mangelen ... og kompleksiteten av nåværende forskningsresultater, i følge ...
(Date:7/2/2015)... ... ... have been used in countless labs for decades. In the past, people had to ... expected, this was a daunting and tiring process looking at endless data tables and charts. ... navigate the complex catalog structure. , Now thanks to FireflySci, scientists are throwing away those ...
Breaking Biology Technology:FireflySci Simplifies the Calibration of UV Spectrophotometers with FUV Photometric Accuracy Standards 2FireflySci Simplifies the Calibration of UV Spectrophotometers with FUV Photometric Accuracy Standards 3The Alexander Group Declares Their Independence with a Bit of Levity 2Lansering av verdens første Open Innovation-program for utdanning av forskere 2Lansering av verdens første Open Innovation-program for utdanning av forskere 3New Cuvette E-Commerce Website Launched by FireflySci 2
... than $120,000 in the prestigious Race Across America the past two years, ... ... Wednesday, June 11,2008, Renato Shaffer will begin riding his bike for the third ... Disease, the fatal,brain disease that affects his wife and threatens his two daughters., ...
... Provid Pharmaceuticals,Inc. and The Leukemia & Lymphoma Society ... agreement to advance the development of a treatment,for ... has contracted with Provid to supply expert,medicinal chemistry ... Research (SCOR) grant at the University of Virginia ...
... most prestigious for leadership and public service, WASHINGTON, ... today announced the appointment of Deirdre P. Connelly to,the ... of U.S. operations for Eli Lilly and Company (NYSE: ... America,s most prestigious program for,leadership and public service," Connelly ...
Cached Biology Technology:HDSA-San Diego's Team 2CureHD Continues its Race to Cure Huntington's Disease 2The Leukemia & Lymphoma Society and Provid Pharmaceuticals Announce Collaboration on Treatment for Acute Myelogenous Leukemia 2The Leukemia & Lymphoma Society and Provid Pharmaceuticals Announce Collaboration on Treatment for Acute Myelogenous Leukemia 3Lilly's Connelly Appointed to the President's Commission on White House Fellowships 2Lilly's Connelly Appointed to the President's Commission on White House Fellowships 3
(Date:6/24/2015)... -- The biologics safety testing market is growing at ... include growth of the pharmaceutical and biological industries and ... years, the number of drug approvals in North American ... approved 225 drug applications and Health Canada approved 99. ... accounted for 3,822 of the pharmaceutical and 1,998 ...
(Date:6/24/2015)... June 24, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced that Sharp has selected its ... authentication for its latest flagship smartphone device, the ... 200 million shipments of its fingerprint ID sensor ... strength, scalability and leadership in the biometrics market ...
(Date:6/24/2015)... 24, 2015 Biometry authentication provider KeyLemon ... password solution one face in. ... one face in, entering the expanding biometric authentication ... multifactor-authentication biometric answer to the password problem. With ... partnership with KeyLemon, one face in allows users ...
Breaking Biology News(10 mins):Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2KeyLemon Announces Partnership With Biometric Password Solution onefacein 2
... finding, new research from North Carolina State University shows that ... the past 3,000 years has actually increased in size, despite ... the area. "What we,ve found indicates that human activity ... a negative impact on a species even a species ...
... filter-feeder, that anchors itself to the sea bed, offers new ... Ice Sheet a region that is thought to be ... for the Census of Antarctic Marine Life (CAML), scientists from ... coastal and deep sea regions around the continent and from ...
... cancer begins has identified adjacent cancer cells that scientists are ... could someday hold the key to predicting, preventing and stopping ... body,s pigment-producing cells, where melanoma - the most dangerous form ... the story, according to a new study by researchers from ...
Cached Biology News:Archaeological study shows human activity may have boosted shellfish size 2Marine animals suggest evidence for a trans-Antarctic seaway 2'Co-conspirator' cells could hold key to melanoma prediction, prevention 2
... MagicMark and MagicMark XP Western ... easy and convenient protein molecular weight ... standard protein contains an IgG binding ... same antibody-conjugate reagents used to detect ...
... TOPO Cloning is the ... for cloning PCR products. ... Zero Blunt TOPO vectors ... activated with topoisomerase I. ...
... Production Conjugated peptides or recombinant ... protocol to produce antibodies in 2 rabbits. ... ELISA test until the titer reaches 1:4,000 ... titer Protein G purification Antibodies are ...
... Clone/PAD: ZMD.420. Immunogen: ... Specificity: Specific for the ... Reactivity: Human (positive control: ... Based on sequence homology reactivity ...
Biology Products: